Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANAB Anaptysbio Inc

盘前交易 04-14 05:25:39 EDT

17.17

+0.93

+5.73%

盘前15.41

-1.76-10.25%

04:16 EDT

最高17.31	最低16.03	成交量75.21万
今开16.32	昨收16.24	日振幅7.88%
总市值5.27亿	流通市值3.10亿	总股本3,067万
成交额1,281万	换手率4.17%	流通股本1,803万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":17.17,"timestamp":1744401600000,"preClose":16.24,"halted":0,"volume":752064,"hourTrading":{"tag":"盘前","latestPrice":15.41,"preClose":17.17,"latestTime":"04:16 EDT","volume":1,"amount":15.41,"timestamp":1744618581990},"delay":0,"floatShares":18032376,"shares":30666781,"eps":-5.11701,"marketStatus":"盘前交易","change":0.93,"latestTime":"04-14 05:25:39 EDT","open":16.32,"high":17.31,"low":16.03,"amount":12807319.01184,"amplitude":0.078818,"askPrice":19.2,"askSize":100,"bidPrice":15.42,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.11701,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1744637400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1485406800000,"exchange":"NASDAQ","adjPreClose":17.17,"preHourTrading":{"tag":"盘前","latestPrice":15.41,"preClose":17.17,"latestTime":"04:16 EDT","volume":1,"amount":15.41,"timestamp":1744618581990},"postHourTrading":{"tag":"盘后","latestPrice":17.17,"preClose":17.17,"latestTime":"17:51 EDT","volume":11005,"amount":188877.15,"timestamp":1744408290894},"volumeRatio":0.766356259976763,"impliedVol":1.3274,"impliedVolPercentile":0.72},"requestUrl":"/m/hq/s/ANAB","defaultTab":"news","newsList":[{"id":"2518540447","title":"Anaptysbio, Inc.2024财年实现净利润-1.45亿美元，同比增加11.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518540447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518540447?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449634,"startTime":"0","endTime":"0","summary":"3月9日，Anaptysbio, Inc.公布财报，公告显示公司2024财年净利润为-1.45亿美元，同比增加11.59%；其中营业收入为91.28百万美元，同比增加431.93%，每股基本收益为-5.12美元。从资产负债表来看，Anaptysbio, Inc.总负债4.13亿美元，其中短期债务1.93百万美元，资产负债比为1.18，流动比率为0.10。机构评级：截至2025年3月9日，当前有11家机构对Anaptysbio, Inc.目标价做出预测，其中目标均价为37.64美元，其中最低目标价为18.00美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000109abef972f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000109abef972f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB"],"gpt_icon":0},{"id":"2517198212","title":"Anaptysbio, Inc.盘中异动 大幅跳水5.07%报15.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517198212?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:12","pubTimestamp":1741281178,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时12分，Anaptysbio, Inc.股票出现波动，股价大幅下跌5.07%。截至发稿，该股报15.90美元/股，成交量14.7412万股，换手率0.48%，振幅4.72%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3191.22%、2706.07%、219.82%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、105.20%、71.44%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307011259a262b72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307011259a262b72b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2517288319","title":"Anaptysbio, Inc.盘中异动 大幅上涨5.05%报16.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517288319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517288319?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:54","pubTimestamp":1741197250,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时54分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报16.02美元/股，成交量18.796万股，换手率0.61%，振幅5.49%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为943.09%、304.49%、296.64%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306015411a260fff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306015411a260fff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2517494863","title":"小摩：维持AnaptysBio(ANAB.US)评级，由增持调整至增持评级, 目标价由36.00美元调整至42.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517494863","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517494863?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:43","pubTimestamp":1741185815,"startTime":"0","endTime":"0","summary":"小摩：维持AnaptysBio(ANAB.US)评级，由增持调整至增持评级, 目标价由36.00美元调整至42.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05224348547984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ANAB"],"gpt_icon":0},{"id":"2517600468","title":"Anaptysbio, Inc.盘中异动 下午盘股价大涨5.09%报15.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517600468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517600468?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:57","pubTimestamp":1741114670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时57分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.09%。截至发稿，该股报15.39美元/股，成交量41.7006万股，换手率1.36%，振幅9.36%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305025751963983e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305025751963983e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2516300176","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516300176?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:40","pubTimestamp":1741016416,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时40分，Anaptysbio, Inc.股票出现异动，股价大幅下跌5.05%。截至发稿，该股报15.97美元/股，成交量12.1312万股，换手率0.40%，振幅7.55%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2270.71%、137.53%、130.63%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、50.09%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303234016abe64b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303234016abe64b2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2514320113","title":"Anaptysbio, Inc.股价拉升13.90% 市值涨7900.87万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320113?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753149,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Anaptysbio, Inc.股票出现异动，股价大幅拉升13.90%。截至发稿，该股报18.68美元/股，成交量1.6566万股，换手率0.05%，振幅6.76%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为483.12%、240.91%、59.40%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Trevi Therapeutics, Inc.、Spyre Therapeutics, Inc.，振幅分别为31.14%、8.44%、8.03%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223229abe0eab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223229abe0eab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2514354511","title":"AnaptysBio(ANAB.US)：2024年Q4财报实现营收4311.3万美元，前值为900.5万美元，预期值为1009万美元；每股收益为-0.72美元，前值为-1.59美元，预期值为-1.74美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354511","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514354511?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697714,"startTime":"0","endTime":"0","summary":"AnaptysBio(ANAB.US)：2024年Q4财报实现营收4311.3万美元，前值为900.5万美元，预期值为1009万美元；每股收益为-0.72美元，前值为-1.59美元，预期值为-1.74美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ANAB"],"gpt_icon":0},{"id":"1185656838","title":"AnaptysBio 2024年第四季度GAAP每股收益$(0.72)超出$(1.62)预期，销售额$43.113百万未达$7.767百万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1185656838","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185656838?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:56","pubTimestamp":1740693386,"startTime":"0","endTime":"0","summary":"AnaptysBio报告季度每股亏损$，比分析师的一致预期$高出55.56%。这比去年同期每股亏损$增加了54.72%。公司报告季度销售额为$43.113百万，未达分析师的一致预期$7.767百万。这比去年同期的$9.005百万减少了100.00%。以上内容来自Benzinga Earnings专栏，原文如下：AnaptysBio  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 55.56 percent. This is a 54.72 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $43.113 which missed the analyst consensus estimate of $7.767 million by 100.00 percent.  Thi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AnaptysBio 2024年第四季度GAAP每股收益$(0.72)超出$(1.62)预期，销售额$43.113百万未达$7.767百万预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB"],"gpt_icon":0},{"id":"2514331713","title":"Anaptysbio, Inc.盘中异动 下午盘股价大跌5.03%报16.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331713?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:33","pubTimestamp":1740684818,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时33分，Anaptysbio, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报16.15美元/股，成交量25.5381万股，换手率0.84%，振幅6.44%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Alpha Tau Medical Ltd C/Wts 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1903.69%、330.34%、183.70%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280333389632e8b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280333389632e8b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2513783137","title":"Anaptysbio, Inc.盘中异动 大幅下跌5.00%报17.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513783137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513783137?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:04","pubTimestamp":1740409470,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时04分，Anaptysbio, Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报17.66美元/股，成交量6.791万股，换手率0.22%，振幅4.46%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为159.65%、70.56%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230430abdb15ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230430abdb15ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2512169455","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.00%报20.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512169455?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:16","pubTimestamp":1739891785,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时16分，Anaptysbio, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报20.16美元/股，成交量14.9729万股，换手率0.49%，振幅6.80%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为352.34%、134.56%、127.46%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Allogene Therapeutics, Inc.，振幅分别为148.75%、51.40%、46.32%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231625988a0646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218231625988a0646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2511691734","title":"Anaptysbio, Inc.盘中异动 早盘急速上涨5.46%报20.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511691734?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.46%。截至发稿，该股报20.34美元/股，成交量5.2291万股，换手率0.17%，振幅5.51%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1852.91%、485.12%、421.78%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Klotho Neurosciences, Inc.，振幅分别为66.93%、32.93%、32.49%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485796231f69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422485796231f69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2511501226","title":"富国银行：维持AnaptysBio(ANAB.US)评级，由增持调整至增持评级, 目标价由40.00美元调整至51.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511501226","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511501226?lang=zh_cn&edition=full","pubTime":"2025-02-14 07:41","pubTimestamp":1739490084,"startTime":"0","endTime":"0","summary":"富国银行：维持AnaptysBio(ANAB.US)评级，由增持调整至增持评级, 目标价由40.00美元调整至51.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14074148151395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ANAB"],"gpt_icon":0},{"id":"2511525181","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨7.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511525181?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457063,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Anaptysbio, Inc.股票出现波动，股价快速拉升7.99%。截至发稿，该股报17.44美元/股，成交量7.5358万股，换手率0.25%，振幅0.80%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为970.14%、764.83%、89.76%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Aim Immunotech Inc.、Aditxt, Inc.，振幅分别为6.98%、5.37%、3.84%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310498842b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322310498842b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2510782335","title":"Anaptysbio, Inc.盘中异动 早盘股价大跌5.15%报12.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510782335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510782335?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:16","pubTimestamp":1739286983,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时16分，Anaptysbio, Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报12.33美元/股，成交量4.3521万股，换手率0.14%，振幅4.77%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为1.58%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2551.71%、838.28%、342.49%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、43.92%、37.99%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231624961f508b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231624961f508b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB","OCEA"],"gpt_icon":0},{"id":"2510613998","title":"Anaptysbio, Inc.盘中异动 股价大跌5.01%报13.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510613998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510613998?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:40","pubTimestamp":1739202058,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时40分，Anaptysbio, Inc.股票出现异动，股价快速下跌5.01%。截至发稿，该股报13.85美元/股，成交量6.669万股，换手率0.22%，振幅5.93%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2608.72%、1529.48%、988.00%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为87.80%、69.83%、66.09%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234058a240b1b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234058a240b1b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2509726621","title":"Anaptysbio, Inc.盘中异动 大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509726621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509726621?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:25","pubTimestamp":1738945515,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时25分，Anaptysbio, Inc.股票出现异动，股价快速下跌5.04%。截至发稿，该股报15.27美元/股，成交量13.1157万股，换手率0.43%，振幅5.78%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为4580.90%、161.00%、99.43%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、53.38%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208002515961b4cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208002515961b4cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2508515457","title":"Anaptysbio, Inc.盘中异动 早盘大幅拉升5.04%报17.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508515457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508515457?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:32","pubTimestamp":1738679541,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时32分，Anaptysbio, Inc.股票出现波动，股价大幅拉升5.04%。截至发稿，该股报17.50美元/股，成交量1.4255万股，换手率0.05%，振幅0.78%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Azitra Inc、Evaxion Biotech As、Invivyd, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为892.76%、686.40%、186.00%，振幅较大的相关个股有Azitra Inc、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Omega Therapeutics, Inc.，振幅分别为29.44%、19.74%、18.97%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042232219617d7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502042232219617d7ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2508149359","title":"Anaptysbio, Inc.盘中异动 急速下跌5.24%报16.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508149359?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593369,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Anaptysbio, Inc.股票出现异动，股价急速跳水5.24%。截至发稿，该股报16.99美元/股，成交量1.2397万股，换手率0.04%，振幅0.89%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为355.70%、311.70%、146.02%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、27.90%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032236099616fc54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032236099616fc54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anaptysbio.com","stockEarnings":[{"period":"1week","weight":-0.0724},{"period":"1month","weight":-0.0305},{"period":"3month","weight":0.2083},{"period":"6month","weight":-0.4831},{"period":"1year","weight":-0.3057},{"period":"ytd","weight":0.2968}],"compareEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":-0.0446},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0787},{"period":"1year","weight":0.0308},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AnaptysBio, Inc.在特拉华成立于2005年11月。该公司是一家临床阶段的生物技术公司，专注于提供创新的免疫学疗法。该公司正在开发免疫细胞调节抗体，包括两种处于临床阶段开发阶段的全资拥有的检查点激动剂，用于自身免疫和炎症性疾病：rosnilimab，公司PD-1激动剂用于治疗中度至重度类风湿性关节炎（“RA”）的2b期试验和治疗中度至重度溃疡性结肠炎（“UC”）的2期试验；ANB032，公司BTLA激动剂，用于治疗中度至重度特应性皮炎（“AD”）的2b期试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.045539},{"month":2,"riseRate":0.777778,"avgChangeRate":0.080411},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.062379},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.00511},{"month":5,"riseRate":0.375,"avgChangeRate":-0.031718},{"month":6,"riseRate":0.625,"avgChangeRate":0.007623},{"month":7,"riseRate":0.5,"avgChangeRate":0.019018},{"month":8,"riseRate":0.625,"avgChangeRate":0.039779},{"month":9,"riseRate":0.5,"avgChangeRate":0.004586},{"month":10,"riseRate":0.625,"avgChangeRate":0.20142},{"month":11,"riseRate":0.25,"avgChangeRate":-0.066751},{"month":12,"riseRate":0.625,"avgChangeRate":0.041626}],"exchange":"NASDAQ","name":"Anaptysbio Inc","nameEN":"Anaptysbio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.0","shortVersion":"4.33.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anaptysbio Inc,ANAB,Anaptysbio Inc股票,Anaptysbio Inc股票老虎,Anaptysbio Inc股票老虎国际,Anaptysbio Inc行情,Anaptysbio Inc股票行情,Anaptysbio Inc股价,Anaptysbio Inc股市,Anaptysbio Inc股票价格,Anaptysbio Inc股票交易,Anaptysbio Inc股票购买,Anaptysbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}